Byung Cheon Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Byung Cheon Lee has a total of 348 co-authors. Here are the top co-authors by number of shared publications:
- Vadim N. Gladyshev
Division of Genetics, Department of Medicine, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA
28 shared publications - Alaattin Kaya
School of Life Sciences and Sustainability, Virginia Commonwealth University
9 shared publications Dolph L. Hatfield
Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, USA
9 shared publicationsHwa-Young Kim
Department of Biochemistry and Molecular Biology, Yeungnam University College of Medicine, Daegu, Republic of Korea
9 shared publicationsVadim N. Gladyshev
Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02215, United States
9 shared publicationsDmitri E. Fomenko
Department of Biochemistry and Redox Biology Center, University of Nebraska, Lincoln, NE, 68588, USA
8 shared publications
Latest Publications
- Open Access
- 30 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
DHRS13 suppresses differentiation and mitophagy in glioma via retinoic acid and mitochondrial reactive oxygen species
To elucidate the complex interplay of undifferentiated cancer cells in malignancy, we focus on the crucial mechanisms that maintain the undifferentiated state of cancer stem-like cells, which drive tumor growth and therapy resistance. Here, we identify a protein called dehydrogenase/reductase 13 (DHRS13) that is abundant in undifferentiated glioblastoma cells. DHRS13 is primarily located in the mitochondria and functions as a retinaldehyde reductase, converting all-trans-retinaldehyde to all-trans-retinol with high affinity for NADPH. Mechanistically, DHRS13 prevents glioma stem-like cells from differentiating by blocking retinoic acid signaling, thereby maintaining their undifferentiated state. Remarkably, the depletion of DHRS13 results in mitochondrial reactive oxygen species-driven mitophagy and cell death. Consequently, loss of DHRS13 leads to a significant decrease in tumor initiation and progression. These findings hold promise for the development of strategies that target undifferentiated cancer cells, potentially leading to improved treatment outcomes.
- 30 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Open AccessDHRS13 suppresses differentiation and mitophagy in glioma via retinoic acid and mitochondrial reactive oxygen species
To elucidate the complex interplay of undifferentiated cancer cells in malignancy, we focus on the crucial mechanisms that maintain the undifferentiated state of cancer stem-like cells, which drive tumor growth and therapy resistance. Here, we identify a protein called dehydrogenase/reductase 13 (DHRS13) that is abundant in undifferentiated glioblastoma cells. DHRS13 is primarily located in the mitochondria and functions as a retinaldehyde reductase, converting all-trans-retinaldehyde to all-trans-retinol with high affinity for NADPH. Mechanistically, DHRS13 prevents glioma stem-like cells from differentiating by blocking retinoic acid signaling, thereby maintaining their undifferentiated state. Remarkably, the depletion of DHRS13 results in mitochondrial reactive oxygen species-driven mitophagy and cell death. Consequently, loss of DHRS13 leads to a significant decrease in tumor initiation and progression. These findings hold promise for the development of strategies that target undifferentiated cancer cells, potentially leading to improved treatment outcomes.
- Open Access
Methionine sulfoxide reductase B3 antioxidant activity is indispensable for mouse inner ear cuticular plate structure and hair bundle integrity
Methionine sulfoxide reductases (MSR) are enzymes responsible for catalyzing the reduction of methionine-sulfoxides. We previously demonstrated that variants in human MSRB3 , a member of the MSR family, are associated with profound autosomal recessive prelingual non-syndromic hearing loss DFNB74. To better understand the role of MSRB3 in the auditory pathway, we generated a complete MsrB3 gene knock-out mouse model of human DFNB74 deafness. The MsrB3 deficient mouse showed profound hearing loss by postnatal day 16 (P16), which was accompanied by hair cell morphological abnormalities including altered stereocilia bundle shape and cuticular plate degeneration followed by hair cell apoptotic death. Although the absence of MSRB3 primarily affected the actin cytoskeleton, rootlets were present, and the expression and localization of major F-actin stereocilia-core proteins were unaltered. Biochemical assays demonstrated that wild-type MSRB3, but not MSRB3 harboring p.Cys89Gly, the same variant reported for human deafness DFNB74, can repolymerize oxidized actin. Consistent with these in vitro data, we observed a decreased ratio of reduced/total actin in the inner ears of Msrb3 knock-out mice. These data suggest a protective role of MSRB3 in the maintenance and maturation of stereocilia and hair cells, a conserved mechanism aimed at maintaining actin redox dynamics in these sensory cells.
Open AccessMethionine sulfoxide reductase B3 antioxidant activity is indispensable for mouse inner ear cuticular plate structure and hair bundle integrity
Methionine sulfoxide reductases (MSR) are enzymes responsible for catalyzing the reduction of methionine-sulfoxides. We previously demonstrated that variants in human MSRB3 , a member of the MSR family, are associated with profound autosomal recessive prelingual non-syndromic hearing loss DFNB74. To better understand the role of MSRB3 in the auditory pathway, we generated a complete MsrB3 gene knock-out mouse model of human DFNB74 deafness. The MsrB3 deficient mouse showed profound hearing loss by postnatal day 16 (P16), which was accompanied by hair cell morphological abnormalities including altered stereocilia bundle shape and cuticular plate degeneration followed by hair cell apoptotic death. Although the absence of MSRB3 primarily affected the actin cytoskeleton, rootlets were present, and the expression and localization of major F-actin stereocilia-core proteins were unaltered. Biochemical assays demonstrated that wild-type MSRB3, but not MSRB3 harboring p.Cys89Gly, the same variant reported for human deafness DFNB74, can repolymerize oxidized actin. Consistent with these in vitro data, we observed a decreased ratio of reduced/total actin in the inner ears of Msrb3 knock-out mice. These data suggest a protective role of MSRB3 in the maintenance and maturation of stereocilia and hair cells, a conserved mechanism aimed at maintaining actin redox dynamics in these sensory cells.
- Open Access
- 2 November 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (11) , 1348
Development and Optimization of a Redox Enzyme-Based Fluorescence Biosensor for the Identification of MsrB1 Inhibitors
MsrB1 is a thiol-dependent enzyme that reduces protein methionine-R-sulfoxide and regulates inflammatory response in macrophages. Therefore, MsrB1 could be a promising therapeutic target for the control of inflammation. To identify MsrB1 inhibitors, we construct a redox protein-based fluorescence biosensor composed of MsrB1, a circularly permutated fluorescent protein, and the thioredoxin1 in a single polypeptide chain. This protein-based biosensor, named RIYsense, efficiently measures protein methionine sulfoxide reduction by ratiometric fluorescence increase. We used it for high-throughput screening of potential MsrB1 inhibitors among 6868 compounds. A total of 192 compounds were selected based on their ability to reduce relative fluorescence intensity by more than 50% compared to the control. Then, we used molecular docking simulations of the compound on MsrB1, affinity assays, and MsrB1 activity measurement to identify compounds with reliable and strong inhibitory effects. Two compounds were selected as MsrB1 inhibitors: 4-[5-(4-ethylphenyl)-3-(4-hydroxyphenyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide and 6-chloro-10-(4-ethylphenyl)pyrimido[4,5-b]quinoline-2,4-dione. They are heterocyclic, polyaromatic compounds with a substituted phenyl moiety interacting with the MsrB1 active site, as revealed by docking simulation. These compounds were found to decrease the expression of anti-inflammatory cytokines such as IL-10 and IL-1rn, leading to auricular skin swelling and increased thickness in an ear edema model, effectively mimicking the effects observed in MsrB1 knockout mice. In summary, using a novel redox protein-based fluorescence biosensor, we identified potential MsrB1 inhibitors that can regulate the inflammatory response, particularly by influencing the expression of anti-inflammatory cytokines. These compounds are promising tools for understanding MsrB1’s role during inflammation and eventually controlling inflammation in therapeutic approaches.
- 2 November 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (11) , 1348
Open AccessDevelopment and Optimization of a Redox Enzyme-Based Fluorescence Biosensor for the Identification of MsrB1 Inhibitors
MsrB1 is a thiol-dependent enzyme that reduces protein methionine-R-sulfoxide and regulates inflammatory response in macrophages. Therefore, MsrB1 could be a promising therapeutic target for the control of inflammation. To identify MsrB1 inhibitors, we construct a redox protein-based fluorescence biosensor composed of MsrB1, a circularly permutated fluorescent protein, and the thioredoxin1 in a single polypeptide chain. This protein-based biosensor, named RIYsense, efficiently measures protein methionine sulfoxide reduction by ratiometric fluorescence increase. We used it for high-throughput screening of potential MsrB1 inhibitors among 6868 compounds. A total of 192 compounds were selected based on their ability to reduce relative fluorescence intensity by more than 50% compared to the control. Then, we used molecular docking simulations of the compound on MsrB1, affinity assays, and MsrB1 activity measurement to identify compounds with reliable and strong inhibitory effects. Two compounds were selected as MsrB1 inhibitors: 4-[5-(4-ethylphenyl)-3-(4-hydroxyphenyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide and 6-chloro-10-(4-ethylphenyl)pyrimido[4,5-b]quinoline-2,4-dione. They are heterocyclic, polyaromatic compounds with a substituted phenyl moiety interacting with the MsrB1 active site, as revealed by docking simulation. These compounds were found to decrease the expression of anti-inflammatory cytokines such as IL-10 and IL-1rn, leading to auricular skin swelling and increased thickness in an ear edema model, effectively mimicking the effects observed in MsrB1 knockout mice. In summary, using a novel redox protein-based fluorescence biosensor, we identified potential MsrB1 inhibitors that can regulate the inflammatory response, particularly by influencing the expression of anti-inflammatory cytokines. These compounds are promising tools for understanding MsrB1’s role during inflammation and eventually controlling inflammation in therapeutic approaches.
- 7 September 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 191, 228-240
The selenoprotein methionine sulfoxide reductase B1 (MSRB1)
- 7 September 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 191, 228-240
The selenoprotein methionine sulfoxide reductase B1 (MSRB1)
- 28 February 2022
- Published by Academic Society of Event and Convention in Journal & Article Management System
- Vol. 45, 1-23
Estimating Sales Volume of the Event Industry and Impact Analysis of the COVID-19
Purpose - The purpose of this study is to estimate the sales volume and employee size of the event industry and to analyze the changes in sales volume and employee size caused by COVID-19 Design, data, and methodology - Based on standard industry classification code (exhibition, convention and event), a total of 5,657 event companies were included as study population. Secondary data of sales and the number of employees from 2018 to 2020 were collected from a reputable credit information company and online survey were also conducted simultaneously. Sales data of 1,435 in 2018, 1,487 in 2019, and 1,032 in 202 were collected and analyzed. Result - The estimated sales of event industry were approximately 10.9 trillion won in 2018, 10.8 trillion won in 2019, and 7.6 trillion won in 2020. Regarding change in sales, it slightly decreased to -0.12% in 2019 compared to 2018, but decreased significantly by -29.7% in 2020 compared to 2019. A total of 81.5% (117 companies) of companies rely on the Event(Event agency) business for sales of more than 50%, indicating that they are very dependent on the Event (Event agency) business. Conclusions - For the continuous growth of the industry, it is necessary to enact an industrial system and industry-related laws through the re-establishment of the concept and scope of the event industry. In line with this, implication and suggestions were discussed.
- 28 February 2022
- Published by Academic Society of Event and Convention in Journal & Article Management System
- Vol. 45, 1-23
Estimating Sales Volume of the Event Industry and Impact Analysis of the COVID-19
Purpose - The purpose of this study is to estimate the sales volume and employee size of the event industry and to analyze the changes in sales volume and employee size caused by COVID-19 Design, data, and methodology - Based on standard industry classification code (exhibition, convention and event), a total of 5,657 event companies were included as study population. Secondary data of sales and the number of employees from 2018 to 2020 were collected from a reputable credit information company and online survey were also conducted simultaneously. Sales data of 1,435 in 2018, 1,487 in 2019, and 1,032 in 202 were collected and analyzed. Result - The estimated sales of event industry were approximately 10.9 trillion won in 2018, 10.8 trillion won in 2019, and 7.6 trillion won in 2020. Regarding change in sales, it slightly decreased to -0.12% in 2019 compared to 2018, but decreased significantly by -29.7% in 2020 compared to 2019. A total of 81.5% (117 companies) of companies rely on the Event(Event agency) business for sales of more than 50%, indicating that they are very dependent on the Event (Event agency) business. Conclusions - For the continuous growth of the industry, it is necessary to enact an industrial system and industry-related laws through the re-establishment of the concept and scope of the event industry. In line with this, implication and suggestions were discussed.
- Top Cited PapersOpen Access
- 9 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Selenophosphate synthetase 1 deficiency exacerbates osteoarthritis by dysregulating redox homeostasis
Aging and mechanical overload are prominent risk factors for osteoarthritis (OA), which lead to an imbalance in redox homeostasis. The resulting state of oxidative stress drives the pathological transition of chondrocytes during OA development. However, the specific molecular pathways involved in disrupting chondrocyte redox homeostasis remain unclear. Here, we show that selenophosphate synthetase 1 (SEPHS1) expression is downregulated in human and mouse OA cartilage. SEPHS1 downregulation impairs the cellular capacity to synthesize a class of selenoproteins with oxidoreductase functions in chondrocytes, thereby elevating the level of reactive oxygen species (ROS) and facilitating chondrocyte senescence. Cartilage-specific Sephs1 knockout in adult mice causes aging-associated OA, and augments post-traumatic OA, which is rescued by supplementation of N-acetylcysteine (NAC). Selenium-deficient feeding and Sephs1 knockout have synergistic effects in exacerbating OA pathogenesis in mice. Therefore, we propose that SEPHS1 is an essential regulator of selenium metabolism and redox homeostasis, and its dysregulation governs the progression of OA.
- 9 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Top Cited PapersOpen AccessSelenophosphate synthetase 1 deficiency exacerbates osteoarthritis by dysregulating redox homeostasis
Aging and mechanical overload are prominent risk factors for osteoarthritis (OA), which lead to an imbalance in redox homeostasis. The resulting state of oxidative stress drives the pathological transition of chondrocytes during OA development. However, the specific molecular pathways involved in disrupting chondrocyte redox homeostasis remain unclear. Here, we show that selenophosphate synthetase 1 (SEPHS1) expression is downregulated in human and mouse OA cartilage. SEPHS1 downregulation impairs the cellular capacity to synthesize a class of selenoproteins with oxidoreductase functions in chondrocytes, thereby elevating the level of reactive oxygen species (ROS) and facilitating chondrocyte senescence. Cartilage-specific Sephs1 knockout in adult mice causes aging-associated OA, and augments post-traumatic OA, which is rescued by supplementation of N-acetylcysteine (NAC). Selenium-deficient feeding and Sephs1 knockout have synergistic effects in exacerbating OA pathogenesis in mice. Therefore, we propose that SEPHS1 is an essential regulator of selenium metabolism and redox homeostasis, and its dysregulation governs the progression of OA.
- Open Access
- 24 December 2021
- Published by Springer Nature in Applied Biological Chemistry
- Vol. 64 (1) , 1-9
Probiotic effect of Lactococcus lactis subsp. cremoris RPG-HL-0136 on intestinal mucosal immunity in mice
Lactococcus lactis subsp. cremoris is a lactic acid bacterium commonly used in the cheese manufacturing industry. It is known to produce antibacterial peptides and has recently received attention for its role as a probiotic strain. Here, we report the isolation of a new strain, Lactococcus lactis subsp. cremoris RPG-HL-0136 (RPG0136) from dried compost, which exhibits strong antibacterial activity. When RPG0136 was fed to mice, it increased the intestinal population of two beneficial bacteria, Lactobacillus and Bifidobacterium, whereas it decreased the intestinal population of two harmful bacteria, Bacteroides and Enterobacter. In addition, it increased the concentration of short-chain fatty acids, including acetic acid, propionic acid, and butyric acid, with a simultaneous decrease in pH, and accelerated the catabolic degradation of proteins, lipids, and starch. Lastly, RPG0136 increased the plasma IgG and intestinal mucosal SIgA concentrations and upregulated Reg3r, MUC1, and MUC2 expression to improve the intestinal mucosal immune function. The results of this study suggest that RPG0136 is a potential probiotic strain that supports the growth of a beneficial microbiome by promoting the synthesis of organic acids and enhancing intestinal immune function.
- 24 December 2021
- Published by Springer Nature in Applied Biological Chemistry
- Vol. 64 (1) , 1-9
Open AccessProbiotic effect of Lactococcus lactis subsp. cremoris RPG-HL-0136 on intestinal mucosal immunity in mice
Lactococcus lactis subsp. cremoris is a lactic acid bacterium commonly used in the cheese manufacturing industry. It is known to produce antibacterial peptides and has recently received attention for its role as a probiotic strain. Here, we report the isolation of a new strain, Lactococcus lactis subsp. cremoris RPG-HL-0136 (RPG0136) from dried compost, which exhibits strong antibacterial activity. When RPG0136 was fed to mice, it increased the intestinal population of two beneficial bacteria, Lactobacillus and Bifidobacterium, whereas it decreased the intestinal population of two harmful bacteria, Bacteroides and Enterobacter. In addition, it increased the concentration of short-chain fatty acids, including acetic acid, propionic acid, and butyric acid, with a simultaneous decrease in pH, and accelerated the catabolic degradation of proteins, lipids, and starch. Lastly, RPG0136 increased the plasma IgG and intestinal mucosal SIgA concentrations and upregulated Reg3r, MUC1, and MUC2 expression to improve the intestinal mucosal immune function. The results of this study suggest that RPG0136 is a potential probiotic strain that supports the growth of a beneficial microbiome by promoting the synthesis of organic acids and enhancing intestinal immune function.
- 22 December 2021
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 7 (1) , 131-141
Biosensor-Linked Immunosorbent Assay for the Quantification of Methionine Oxidation in Target Proteins
Methionine oxidation is involved in regulating the protein activity and often leads to protein malfunction. However, tools for quantitative analyses of protein-specific methionine oxidation are currently unavailable. In this work, we developed a biological sensor that quantifies oxidized methionine in the form of methionine-R-sulfoxide in target proteins. The biosensor “tpMetROG” consists of methionine sulfoxide reductase B (MsrB), circularly permuted yellow fluorescent protein (cpYFP), thioredoxin, and protein G. Protein G binds to the constant region of antibodies against target proteins, specifically capturing them. Then, MsrB reduces the oxidized methionine in these proteins, leading to cpYFP fluorescence changes. We assessed this biosensor for quantitative analysis of methionine-R-sulfoxide in various proteins, such as calmodulin, IDLO, LegP, Sacde, and actin. We further developed an immunosorbent assay using the biosensor to quantify methionine oxidation in specific proteins such as calmodulin in animal tissues. The biosensor-linked immunosorbent assay proves to be an indispensable tool for detecting methionine oxidation in a protein-specific manner. This is a versatile tool for studying the redox biology of methionine oxidation in proteins.
- 22 December 2021
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 7 (1) , 131-141
Biosensor-Linked Immunosorbent Assay for the Quantification of Methionine Oxidation in Target Proteins
Methionine oxidation is involved in regulating the protein activity and often leads to protein malfunction. However, tools for quantitative analyses of protein-specific methionine oxidation are currently unavailable. In this work, we developed a biological sensor that quantifies oxidized methionine in the form of methionine-R-sulfoxide in target proteins. The biosensor “tpMetROG” consists of methionine sulfoxide reductase B (MsrB), circularly permuted yellow fluorescent protein (cpYFP), thioredoxin, and protein G. Protein G binds to the constant region of antibodies against target proteins, specifically capturing them. Then, MsrB reduces the oxidized methionine in these proteins, leading to cpYFP fluorescence changes. We assessed this biosensor for quantitative analysis of methionine-R-sulfoxide in various proteins, such as calmodulin, IDLO, LegP, Sacde, and actin. We further developed an immunosorbent assay using the biosensor to quantify methionine oxidation in specific proteins such as calmodulin in animal tissues. The biosensor-linked immunosorbent assay proves to be an indispensable tool for detecting methionine oxidation in a protein-specific manner. This is a versatile tool for studying the redox biology of methionine oxidation in proteins.
- Open Access
- 1 April 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 178, 113031
Development of a novel fluorescent biosensor for dynamic monitoring of metabolic methionine redox status in cells and tissues
- 1 April 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 178, 113031
Open AccessDevelopment of a novel fluorescent biosensor for dynamic monitoring of metabolic methionine redox status in cells and tissues
- Open Access
- 12 February 2021
- Published by Springer Nature in Applied Biological Chemistry
- Vol. 64 (1) , 1-7
Physalis alkekengi L. var. francheti alleviates neuronal cell death caused by activated microglia in vitro
Microglia are the macrophages that reside in the brain. Activated microglia induces further activation of astrocytes and neuronal cells for mounting an immune response. However, activated microglia release neurotoxic mediators causing neuroinflammation, which is associated with chronic etiology of neurodegenerative diseases. We investigated the effect of ethanol extract of Physalis alkekengi L. var. francheti fruit (PAFE) on neuronal cell death mediated by activated microglia. PAFE decreased NO production and IL-6 secretion in LPS-stimulated BV-2 and primary microglial cells without reducing cell viability. Consistently, treatment with PAFE decreased iNOS and COX-2 expression and ERK phosphorylation in LPS-stimulated BV-2 cells. Finally, apoptosis of N2a cells grown in conditioned media prepared from LPS-stimulated BV-2 cells containing PAFE was inhibited via downregulation of the Bax/Bcl-2 ratio. Taken together, PAFE alleviates neuronal cell death by reducing neurotoxic mediators such as NO and IL-6 from activated microglia. Therefore, it could be a potential candidate to treat neurodegenerative diseases caused by chronic neuroinflammation.
- 12 February 2021
- Published by Springer Nature in Applied Biological Chemistry
- Vol. 64 (1) , 1-7
Open AccessPhysalis alkekengi L. var. francheti alleviates neuronal cell death caused by activated microglia in vitro
Microglia are the macrophages that reside in the brain. Activated microglia induces further activation of astrocytes and neuronal cells for mounting an immune response. However, activated microglia release neurotoxic mediators causing neuroinflammation, which is associated with chronic etiology of neurodegenerative diseases. We investigated the effect of ethanol extract of Physalis alkekengi L. var. francheti fruit (PAFE) on neuronal cell death mediated by activated microglia. PAFE decreased NO production and IL-6 secretion in LPS-stimulated BV-2 and primary microglial cells without reducing cell viability. Consistently, treatment with PAFE decreased iNOS and COX-2 expression and ERK phosphorylation in LPS-stimulated BV-2 cells. Finally, apoptosis of N2a cells grown in conditioned media prepared from LPS-stimulated BV-2 cells containing PAFE was inhibited via downregulation of the Bax/Bcl-2 ratio. Taken together, PAFE alleviates neuronal cell death by reducing neurotoxic mediators such as NO and IL-6 from activated microglia. Therefore, it could be a potential candidate to treat neurodegenerative diseases caused by chronic neuroinflammation.